AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintains durable improvement across multiple treatment cycles.

Khashayar DashtipourStefan WietekBruce RubinPascal MaisonobeLaxman BahrooRichard Trosch

Published in: Journal of clinical movement disorders (2020)

ClinicalTrials.gov Identifier: NCT01753336. Registered 17 Dec 2012.

Keyphrases